Development of Electrospun Chitosan-Polyethylene Oxide/Fibrinogen Biocomposite for Potential Wound Healing Applications
Normal wound healing is a highly complex process that requires the interplay of various growth factors and cell types. Despite advancements in biomaterials, only a few bioactive wound dressings reach the clinical setting. The purpose of this research was to explore the feasibility of electrospinning a novel nanofibrous chitosan (CS)-fibrinogen (Fb) scaffold capable of sustained release of platelet-derived growth factor (PDGF) for the promotion of fibroblast migration and wound healing. CS-Fb scaffolds were successfully electrospun using a dual-spinneret electrospinner and directly evaluated for their physical, chemical, and biological characteristics. CS-polyethylene/Fb scaffolds exhibited thinner fiber diameters than nanofibers electrospun from the individual components while demonstrating adequate mechanical properties and homogeneous polymer distribution. In addition, the scaffold demonstrated acceptable water transfer rates for wound healing applications. PDGF was successfully incorporated in the scaffold and maintained functional activity throughout the electrospinning process. Furthermore, released PDGF was effective at promoting fibroblast migration equivalent to a single 50 ng/mL dose of PDGF. The current study demonstrates that PDGF-loaded CS-Fb nanofibrous scaffolds possess characteristics that would be highly beneficial as novel bioactive dressings for enhancement of wound healing.
KeywordsElectrospinning Biomedical applications Chitosan Wound dressing Fibrinogen Nanofibers PDGF Wound healing
Degree of acetylation
Eagle’s minimum essential media
Fibroblast blast media
Field emission scanning electron microscope
Fibroblast growth factor
Platelet-derived growth factor
Transforming growth factor beta
Time-of-flight secondary ion mass spectrometry
Vascular endothelial growth factor
Water vapor transfer rate
Despite numerous advances made in the field of wound management, few bioactive dressings have been commercialized with the capacity to enhance the healing process. This lack of successful product can be attributed to the complexity of the wound healing process, which involves numerous soluble mediators, blood cells, parenchymal cells, and extracellular matrix (ECM) components. Growth factors play a central role in the wound healing process by promoting cell proliferation, migration, and differentiation. However, rapid elimination and short half-lives in the body [1, 2, 3] have limited the clinical adoption of growth factor therapy for promotion of healing and tissue regeneration [4, 5]. Currently, repetitive in vivo administration of growth factors is required to achieve therapeutic effects (e.g., cellular recruitment and differentiation). The development of a wound dressing that is capable of sustained, localized growth factor delivery would significantly improve treatment outcomes and accelerate clinical adoption.
Platelet-derived growth factor (PDGF) plays a critical role as an initiator and mediator of wound healing; it acts as a chemotactic agent for neutrophils, monocytes, and fibroblasts  and helps regulate matrix deposition. In addition, PDGF can inhibit differentiation of fibroblasts into myofibroblasts, which can impact wound contractions and decrease scar formation . PDGF, sold under the brand name Regranex®, is the only growth factor currently approved by the FDA and is intended for the treatment of lower extremity diabetic ulcers. Once daily topical application of Regranex® gel (2.2 μg/cm2 of ulcer) has been shown to result in a 30% faster healing time with minimal adverse effects. However, daily topical application and removal of Regranex® is inconvenient and can adversely impact patient quality of life.
Electrospinning has been established as a notable technique in the fabrication of biomimetic nanofibrous scaffolds using biologically significant polymers. Numerous biodegradable synthetic (e.g., polycaprolactone) and natural polymers (e.g., collagen) have been electrospun into non-woven nanofibrous scaffolds that demonstrate high surface area-to-volume ratios and porosity characteristics, which are important for drug delivery and wound dressing applications. Naturally occurring polymers (e.g., collagen, elastin, and fibrinogen) are particularly attractive wound dressing materials due to their bioactivity, biocompatibility, and unique ability to bind specific growth factors, such as PDGF. Fibrinogen (Fb), a 340-kDa globular plasma protein, plays a major role in clot formation through its activated form, fibrin, which functions as a temporary matrix for tissue repair and regeneration. The absence of Fb and fibrin has been correlated with wound healing defects . Fb-based products demonstrate biodegradability, non-immunogenicity, and cellular migration promotion and have been previously developed as hydrogels [8, 9, 10] and wet extrusion cables [11, 12]; however, the physical and structural properties of these materials have limited their clinical adoption. Hydrogels lack structural and mechanical integrity for long-term use, and wet extrusion fibers exhibit exponentially larger diameter sizes (200–250 μm) than the native ECM (200–500 nm). Wnek et al. demonstrated that electrospinning, however, offers the capability to fabricate Fb scaffolds that closely resemble natural ECM structures . Although the resulting nanofibers exhibited improved mechanical properties over hydrogels, the structure still lacked optimum mechanical properties for wound dressing applications .
To improve the mechanical properties of electrospun fibrinogen scaffold, additional polymer could be introduced to strengthen the nanofibers . Specifically, chitosan (CS), an N-deacetylated derivative of chitin, has been shown to produce desirable antimicrobial properties in wound dressing applications [16, 17]. In addition to being a potent antimicrobial, CS has been electrospun for various biomedical applications including guided bone regeneration [18, 19], transdermal drug delivery , directed stem cell differentiation , and hemostat . Due to the polycationic nature of chitosan, there are significant difficulties in electrospinning using common solvents. To overcome these difficulties and improve electrospinninability, CS has been mixed with various other polymers such as poly(vinyl pyrrolidone) , poly(ethylene oxide) (PEO) , and poly(vinyl alcohol) . Similarly, the polycationic nature of CS has limited successful combination with Fb into a single scaffold due to strong electrostatic interactions. In this work, this limitation was overcome by utilizing a versatile dual-nozzle electrospinning system. The resultant nanofibrous scaffolds were analyzed using various physiochemical characterizations. We hypothesized that the novel combinatory CS-Fb nanofibrous scaffold would present a viable candidate for a bioactive and biomimetic wound dressing that could deliver PDGF and could be effective in influencing fibroblast migration required for wound healing.
Acetic acid (glacial, ≥ 99.85%), CS (low molecular weight, 75–85% deacetylation), PEO (MW 300,000 g/mol), Fb (type I-S, 65–85% protein), 1,1,1,3,3,3-hexafluoroisopropanol (HFIP), and bovine serum albumin (BSA, ≥ 96%) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dimethyl sulfoxide (DMSO) was purchased from EMD Millipore (Billerica, MA, USA). Human dermal fibroblasts (PCS-201-012) and cell culture reagents were purchased from American Type Culture Collection (Manassas, VA, USA). Carrier-free recombinant human platelet-derived growth factor-BB (rhPDGF-BB) was purchased from PeproTech (Rocky Hill, NJ, USA). All reagents were of reagent grade and used without further purification or modification.
Preparation of Electrospun Chitosan-Polyethylene Oxide/Fibrinogen Composite Scaffolds
Nanofiber Morphology and Diameter
Electrospun nanofibrous scaffolds were sputter-coated with gold and observed using field emission scanning electron microscopy (FESEM) (Zeiss Sigma VP-40, Germany). Twenty micrographs were taken per scaffold, and three individually spun scaffolds were analyzed per formulation. Mean nanofiber diameters were calculated by measuring five random points per micrograph using ImageJ (NIH, Bethesda, MD). A total number of 100 measurements were made per scaffold formulation.
Surface Chemistry Characterization
Time-of-flight ion mass spectrometry (ToF-SIMS) was used to analyze the surface chemistry and the polymer component contributions in the scaffold. ToF-SIMS is a sensitive and in-depth surface analytical methodology which assesses the chemical composition of the top nanometer layer of a material by bombardment with high-energy Bi32+ clusters under ultra-high vacuum [25, 26]. Secondary ion fragments ejected from the material surface are then analyzed based on their atomic mass to charge (m/z) ratios and used to infer the overall surface chemical composition.
ToF-SIMS analysis was performed by Evans Analytics Group (EAG, Sunnyvale, CA) using a ToF-SIMS IV (Ion-ToF GmBH, Germany) with a bismuth liquid metal ion gun (30 kV). The instrument was operated in an ion microprobe mode where three positive and negative ion spectra were acquired from each sample. Selected positive and negative ions were mapped over a 50 × 50-μm raster area with a 2048 × 2048-pixel image resolution to provide polymer component mapping of the scaffolds. A normalized intensity, defined as the count of each secondary ion divided by the total count of ions recorded multiplied by 10,000, was reported for each fragment. The mean of three different locations on the surface of six independently fabricated samples was analyzed (n = 6). CS-PEO and Fb polymer distribution analyzed by ToF-SIMs was representative of the whole scaffold.
Water contact angles of CS-PEO, CS-PEO/Fb, and Fb scaffolds were determined in accordance with the American Standards for Testing Methods (ASTM) D7334-08. Nanofibrous scaffolds were electrospun onto glass coverslips. A single droplet of distilled water (2 μL) was applied to the surface of the scaffold and the contact angle measured within 30 s using Krüss DSA10 MK2 Drop Shape Analyzer (Krüss, Hamburg, Germany). The measurements were repeated three times at different locations for each sample, and the mean contact angle was calculated. Six independently electrospun scaffolds were analyzed (n = 6).
Mechanical Uniaxial Tensile Strength
The mechanical properties of electrospun scaffolds were measured at room temperature using an Instron® E3000 ElectroPuls (Instron, Canton, MA) equipped with a 250-N load cell at a strain rate of 1 mm min−1. The thickness of the samples was measured at six random positions by Keyence 3D Laser Scanning Microscope VK-200 (Keyence, Itasca, IL). The thickness of the scaffolds used for tensile testing was 93.8 ± 7.4 μm. Before the test, the scaffolds were cut into 40 × 25-mm rectangular specimens. Data obtained were reported and plotted as stress-strain curves, where tensile stress was defined as the ratio of force to the cross-sectional area of the specimen and where the strain was defined as the change in length over the original length. Young’s moduli, tensile stress, and strain-at-break calculations were obtained from stress-strain curves from an average of ten samples per formulation.
Water Vapor Transfer Rate
In Vitro Cell Viability
Indirect cytotoxicity of the scaffolds was evaluated based on an approach adapted from the ISO10993-5 standard test method [27, 28]. Human dermal fibroblasts were cultured at 37 °C and 5% CO2 in serum-free fibroblast media and refreshed every 3 days. Once the cells reached confluence, they were trypsinized and seeded into 12-well plates (10,000 cells/mL). The following day, media were replenished and nanofibrous scaffolds were introduced. Cell proliferation was monitored over 120 h using a 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium sodium (WST-1) cell proliferation assay.
Visualization of Fibroblasts
Human dermal fibroblasts were trypsinized and seeded onto CS-PEO, Fb, and CS-PEO/Fb scaffolds. After 24 h of incubation at 37 °C and 5% CO2, the cells were washed and stained with LIVE/DEAD™ cell viability kit (ThermoFisher Scientific, Waltham, MA, USA) according to manufacturer’s specifications. Additionally, adhesion and attachment of human fibroblasts to the scaffold were evaluated by staining with Phalloidin-Atto 565 (Sigma Aldrich and 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI; ThermoFisher Scientific) according to manufacturer’s specifications. Images were observed and taken using an inverted confocal microscope (Nikon C1, C1EZ, Melville, NY, USA).
In Vitro Degradation
PDGF Release and Detection
Eluates, collected from specific time points during in vitro degradation experiment, were assayed using a rhPDGF-BB-specific ELISA Kit (R&D System, Minneapolis, MN). Detected absorbance values were compared to a standard, as specified by the manufacturer’s instructions for determination of PDGF concentration. The amount of PDGF detected was normalized to the weight (mg) of the corresponding scaffold used.
Migratory Property of Released Platelet-Derived Growth Factor
Migration of human dermal fibroblasts was evaluated using ORIS™ cell migration assay kit (Platypus Technologies, Madison, WI) to assess PDGF bioactivity. Briefly, fibroblasts treated with mitomycin C (Sigma-Aldrich, St. Louis, MO) were trypsinized and seeded into 96-well plates containing stoppers provided by the manufacturer and incubated at 37 °C and 5% CO2 overnight. The following day, stoppers were removed creating migration zones to which 100 μL of eluates collected at various time points was added and incubated for an additional 24 h. Freshly prepared 50 ng mL−1 PDGF and basal fibroblast media were used as positive and negative controls, respectively. Fibroblast migration was expressed as a fold change, compared to the migration elicited by the 50 ng mL−1 PDGF treatment. Studies were performed in triplicate in three independent experiments for three loading concentrations (2, 4, and 8 μg/mL).
Continuous data were expressed as means ± standard deviations. Differences among group means were analyzed using one-way analysis of variance (ANOVA). Tukey’s multiple comparison test was used to determine which means among a group of means were statistically different. Statistical significance was set at α = 0.05. All data were analyzed using GraphPad Prism (San Diego, CA, USA).
Results and Discussion
The combination of various polymers has been shown to significantly improve the properties of the resulting composite [29, 30]. Combinatory polymer systems effectively allow for the modulation of scaffold strength, flexibility, biodegradation, and drug release kinetics, which are important parameters for wound dressing applications. However, the creation of unique composites can be limited by intrinsic chemical interactions between the constituent polymers. For example, a polymer precipitate was observed to form when mixing negatively charged Fb and positively charged CS; this observation is well-documented for molecules with strong electrostatic interactions under various solvent conditions [31, 32, 33]. Consequently, fabrication of a CS-Fb polymer composite scaffold required the use of a dual extrusion electrospinning technique, as previously described .
Morphology of CS-PEO/Fb Nanofibers
Surface Chemistry Characterization via ToF-SIMS and Water Contact Angle
Mechanical Uniaxial Tensile Strength of CS-PEO/Fb Scaffolds
Uniaxial tensile properties of electrospun scaffolds (n = 10)
Young’s modulus (MPa)
Tensile stress (MPa)
Strain at break (%)
78.12 ± 15.24*
7.27 ± 3.00*
9.88 ± 2.69
18.84 ± 5.19
1.28 ± 0.38
8.25 ± 1.70
6.49 ± 1.89*
0.37 ± 0.10*
26.44 ± 8.58*
Water Vapor Transfer Rate of CS-PEO/Fb Scaffolds
In Vitro Cellular Viability of Human Dermal Fibroblasts
The decreased proliferative capacity may be due to the degree of acetylation (DA) associated with CS, which has been shown to have strong cellular interactions through its positive charges . Younes et al. demonstrated bladder carcinoma cells treated with CS (> 50% DA) significantly reduced viability after 24 h, suggesting CS cytotoxicity is directly related to its DA which can impact proliferation . This effect may also be isolated to in vitro experimental conditions; previous studies have shown CS to be non-toxic in vivo, as its biodegradation products could be cleared through metabolic pathways . Residual HFIP from the electrospinning process may also contribute to the observed cytotoxicity. However, the same cytotoxicity was not observed in the electrospun pure Fb scaffold, which was also prepared in HFIP. HFIP was likely eliminated from electrospun scaffolds during the fabrication process due to its high volatility. An observable decrease in cell viability would be evident if residual HFIP incorporated into the fiber system was being released during timed exposure to human dermal fibroblasts.
LIVE/DEAD Assay and Cellular Attachment
Fibrinogen serves as an important mediator of cellular attachment and growth during wound healing. Phalloidin stains cellular actin filaments allowing for visualization of fibroblast attachment. Figure 9c, d shows the actin filament morphology of the fibroblasts on the surface of fibronectin-coated glass, unloaded CS-PEO/Fb scaffolds, and PDGF-loaded CS-PEO/Fb scaffolds. Overall, normal fibroblast morphology was observed, with the exception of some rounder cells being present on the scaffold samples. The changes in morphology may be attributed to the presence of CS, as shown in previous studies . Alternatively, the differences could be due to the small porosity of the scaffold and dimensionality of the fiber surface in comparison to the flat surface of the control.
In Vitro Degradation of Electrospun CS-PEO/Fb Scaffolds
In Vitro Release of PDGF
During the in vitro degradation, CS-PEO/Fb scaffolds exhibited a unique biphasic release profile, with 21.6 ± 0.1% of the total eluted PDGF being detected in the first hour followed by linear release kinetics. This observation was thought to be a result of the combined polymers and highlighted the functional importance of Fb as a reservoir for the sustained release of biologically critical molecules. Growth factors (e.g., PDGF/VEGF, FGF, and TGF-β families) have been shown to bind the Fb heparin domain with high affinity and have been reported to retain their bioactivity for over 7 days [48, 49, 50].
Effects of Released PDGF on Fibroblast Migration
Eluates collected from electrospun scaffolds, which were loaded with 4 or 8 μg PDGF/mL polymer solutions, demonstrated similar levels of fibroblast migration when compared to a single 50 ng/mL treatment. The data suggest that PDGF delivered by electrospun nanofibers can be equally effective in promoting fibroblast migration as a single application of PDGF. Additionally, the migration elicited by the scaffold-released PDGF was sustained for 48 h. Sustained delivery of PDGF eliminates the need for daily applications, which is an advantage over commercially available treatments such as Regranex®.
Fibroblast migration reached a maximum when cells were treated with the 24-h eluates from each of the PGDF-loaded scaffolds. Notably, when fibroblasts were treated with the 6-h eluates from the 4 and 8 μg PDGF/mL electrospun scaffolds, the same level of maximum migration was achieved. This suggests that the rate of migration increased in response to increased PDGF loading. Additionally, 4 and 8 μg/mL PDGF-loaded scaffolds might be able to elicit fibroblast migration potentials beyond the detection limits of the current assay, which can only assess the endpoint of migration, but not the migration rate. Finally, results demonstrated that eluates from unloaded CS-PEO/Fb scaffolds were also capable of eliciting a linear increase in migration over the same elution time points, albeit less effectively than the PDGF-loaded scaffolds. This result is most likely mediated by the ability of fibrinogen to enhance fibroblast migration [54, 55]. In general, PDGF-loaded composite scaffolds significantly improved in vitro migration, compared to the individual components of the scaffold.
The versatility of electrospinning allows for the combination of advantageous properties of various polymers and proven bioactive molecules. We utilized this technique to fabricate unique CS-PEO/Fb scaffolds with the ability to release biologically active PDGF over 48 h. This study evaluated the chemical and physical properties of the nanofibrous scaffolds including (1) morphology, (2) physical and mechanical properties, (3) in vitro scaffold degradation, and (4) the ability to release functional PDGF in a dose- and time-dependent manner. Electrospun CS-PEO/Fb scaffolds demonstrated nanoscale morphological properties that are conducive to wound dressing applications, as well as an adequate WVTR, mechanical stability, and a unique biphasic PDGF delivery profile. Furthermore, PDGF maintained its biological function throughout the electrospinning process, and when combined with the natural, chemotactic properties of Fb elicited dermal fibroblast migration that is functionally equivalent to a single 50 ng/mL dose of PDGF. Overall, these results highlight the potential of CS-PEO/Fb scaffolds as a viable wound dressing capable of delivering bioactive PDGF to enhance fibroblast recruitment and wound healing.
The authors would like to thank Dr. Tao You of the US Army Institute of Surgical Research for his valuable contributions on the FESEM images.
The views expressed in this manuscript are those of the author and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the US Government. This work was funded by Naval Medical Research Center’s Advanced Medical Development Program using WUN G1406. The study was approved by the Naval Medical Research Unit San Antonio. The authors are employees of the US Government or military service members. This work was prepared as part of their official duties. Title 17 USC §105 provides that “copyright protection under this title is not available for any work of the US Government.” Title 17 USC §101 defines a US Government work as a work prepared by a military service member or employee of the US Government as part of that person’s official duties. Approved for public release; distribution is unlimited.
Availability of Data and Materials
All datasets are presented in the main paper or in additional supporting files.
TTY, MCJ, and AMDF designed the experiments. TTY and MCJ prepared the electrospun scaffolds and performed the scaffold degradation experiments. TTY and JMS provided critical insight and analysis of the data. AMDF performed and analyzed the cell experiments related to biocompatibility and migration. ARJC provided critical discussion of the contents and drafting of the manuscript. All authors read and approved the final manuscript.
TTY, ARJC, and JMS are research scientists at the Naval Medical Research Unit San Antonio. AMDF and MCJ are research associates at the Naval Medical Research Unit San Antonio.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 16.Yuan TT, Jenkins PM, DiGeorge Foushee AM, Jockheck-Clark AR, Stahl JM (2016) Electrospun chitosan/polyethylene oxide nanofibrous scaffolds with potential antibacterial wound dressing applications. J Nanomater 2016:25Google Scholar
- 18.He Y, Liu X, Tang X (2015) In vitro study of electrospun polycaprolactone/chitosan nano fiber membrane guided bone regeneration. Shanghai J Stomatol 24(2):129–134Google Scholar
- 31.Zhang W, Zhong D, Liu Q, Zhang Y, Li N, Wang Q et al (2013) Effect of chitosan and carboxymethyl chitosan on fibrinogen structure and blood coagulation. J Biomed Sci 24(13):1549–1563Google Scholar
- 43.Xu R, Xia H, He W, Li Z, Zhao J, Liu B, et al (2016) Controlled water vapor transmission rate promotes wound-healing via wound re-epithelialization and contraction enhancement. Sci Rep 2016;6:24596Google Scholar
- 50.Sahni A, Francis CW (2000) Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96(12):3772–3778Google Scholar
- 55.Brown LF, Lanir N, McDonagh J, Tognazzi K, Dvorak AM, Dvorak HF (1993) Fibroblast migration in fibrin gel matrices. Am J Pathol 142(1):273Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.